CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

Neutral
AI Analysis

Summary

Virax Biolabs Group Limited closed the exercise of preferred investment options, raising $3.3 million gross proceeds through the purchase of 548,000 ordinary shares.

Importance:2/10
Sentiment:
0.20
capital_raisepreferred_sharesequity_offering
Related Companies

Read the original article

Published by PR Newswire Biotech on July 10, 2026 8:05 PM

Read Original